Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 115,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 115,000 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 93,000 | n/a |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 93,000 | n/a |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 92,000 | n/a |
| Dec 9, 2022 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 16,860 | $46.9K |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 91,000 | n/a |
| Jun 21, 2021 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 91,000 | n/a |
| Jun 19, 2020 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 108,000 | n/a |
| Jun 10, 2020 | Celldex Therapeutics, Inc. (CLDX) | Purchase | 5,000 | $15.0K |